US Digital Pathology 2022
29 September 22
| Eder Lagemann and Sidney Tate
Digital pathology for primary diagnosis is nascent in the US, but it is primed for rapid growth, similar to what is currently being seen in Europe (see KLAS’ report on global digital pathology ). In anticipation, many technology vendors are vying for a foothold in the US, leading to a highly varied landscape. In partnership with the Digital Pathology Association (DPA), KLAS surveyed 55 provider organizations (including hospitals, health systems, academic health centers, and reference labs) to assess the state of digital pathology among pioneers in the US and determine which vendors are gaining traction. 33 of the interviewed organizations are live with digital pathology; the rest are currently implementing or making plans for the future.
Latest Comments See all (13) comments Filtered view: (Europe) ##.#% ##.#% ##.#% Download as Excel
Director
Product
I like the image quality and the possibility of managing some...
Director
Product
The biggest opportunities for product improvement would be adding...
Director
Relationship
A change that the vendor could make to improve our experience as a...
VP/Other Executive
Relationship, Operations
Our transition to digital pathology with Philips couldn’t be better....
VP/Other Executive
Product
IntelliSite Pathology Solution should integrate different AI...
VP/Other Executive
Operations
The implementation is part of the plan from Philips, though it is not...
VP/Other Executive
Product, Value
If a good integration is done with the laboratory system and the IT...
Physician
Product
We want improvements to AI integration and DICOM.
Physician
Product
We like the product's robustness.
Director
Loyalty, Product
There are few updates with IntelliSite Pathology Solution. We have...